S1753Referred to Committee

End Price Gouging for Medications Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-05-14
Introduced
3
Cosponsors
S
ⓘ
Type

Sponsor

Jeff Merkley
Jeff Merkley
Democrat · OR · Senator
Votes with party: 65.3% (323 recorded votes)

Full profile: /officials/M001176

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

3 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2025-05-14

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The proposal would allow the federal government to investigate and take action against pharmaceutical companies that dramatically raise drug prices without justification, particularly during emergencies or public health crises. It would give regulators tools to prevent sudden, extreme price increases on existing medications that patients depend on, affecting both individual consumers and insurance companies that pay for prescriptions. The measure aims to make essential medicines more affordable while still allowing companies to profit from their products.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.